Supporting the hypothesis of a neurobiological link between AD and COVID-19 mortality, a recent pathological examination of post-mortem tissue from AD patients demonstrated that the protein expression levels of angiotensin-converting enzyme 2 (ACE2), the entry receptor for SARS-CoV-2, were upregulated in the brains of AD patients [46]. Here, ACE2 is linked to COVID-19.